11 December 2019 : Laboratory Research
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
Tao Liu1ABCDEF, Chenyao Li1AB, Lipeng Jin1BD, Chao Li1ACDEF*, Lei Wang1ABCDEFGDOI: 10.12659/MSM.920381
Med Sci Monit 2019; 25:9435-9445
Abstract
BACKGROUND: The RNA-seq FPKM data of 331 colorectal adenocarcinoma samples in The Cancer Genome Atlas database with matching clinical data were analyzed in order to reveal the prognostic value of m6A RNA methylation regulators in colon adenocarcinoma.
MATERIAL AND METHODS: The expression of 13 m6A RNA methylated regulators in samples were analyzed. The samples were classified into Cluster I and II by consistent clustering. The gene distribution was analyzed by principal component analysis. Further functional analysis of selected m6A RNA genes was performed and potential risk characteristics was developed using Lasso Cox regression algorithm. Using minimum criteria, the risk coefficients of YTHDF1 and HNRNPC were detected for Cluster II. Patients were divided into high-risk and low-risk subgroups based on the risk characteristics. The clinical data were analyzed by univariate and multivariate Cox regression analysis.
RESULTS: Expression of the detected m6A RNA methylated regulators except YTHDC2 in tumors were significantly different from their adjacent mucosa. Among them, only ALKBH5 and METTL4 were downregulated in tumors. The gene distribution between the 2 subgroups were different. The expression of m6A RNA methylation regulators including YTHDF1, HNRNPC, YTHDC2, YTHDC1, ZC3H13, and RBM15 were different between the 2 groups (P<0.05). The prognostic characteristics between the high-risk and low-risk groups were significant different (P<0.05), which had a good predictive significance of prognosis area under the curve (AUC)=0.62). Risk scores were less than 0.05, suggesting risk score was an independent prognostic factor for colon adenocarcinoma.
CONCLUSIONS: m6A RNA methylation regulators YTHDF1 and HNRNPC can be used as prognostic factors of colon cancer, which has potential value for colon cancer treatment.
Keywords: Colorectal Neoplasms, Hereditary Nonpolyposis, Methyltransferases, RNA Processing, Post-Transcriptional, Adenosine Triphosphatases, Algorithms, Cluster Analysis, Colon, Colonic Neoplasms, Databases, Genetic, Gene Expression Profiling, Heterogeneous-Nuclear Ribonucleoprotein Group C, Methylation, Multivariate Analysis, RNA, RNA Helicases, RNA-Binding Proteins, tRNA Methyltransferases
Editorial
01 June 2024 : Editorial
Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other MammalsDOI: 10.12659/MSM.945315
Med Sci Monit 2024; 30:e945315
In Press
Clinical Research
Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.944263
Clinical Research
Morphological and Dimensional Analysis of the Nasopalatine Canal: Insights from Cone-Beam Computed Tomograp...Med Sci Monit In Press; DOI: 10.12659/MSM.944424
Clinical Research
Hemorrhagic Cysts in the Pancreas: Risk Factors, Treatment, and Outcomes – Insights from a Single-Center StudyMed Sci Monit In Press; DOI: 10.12659/MSM.941955
Clinical Research
Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Managem...Med Sci Monit In Press; DOI: 10.12659/MSM.944063
Most Viewed Current Articles
14 Dec 2022 : Clinical Research 1,421,178
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
17 Jan 2024 : Review article 1,355,487
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 690,090
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial 50,113
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952